LayerBio is a clinical-stage biotechnology company developing sustained-release drug delivery solutions for ophthalmology. Its proprietary OcuRing™ platform is designed to enable precise, localized delivery of therapeutics within the eye, improving efficacy, safety, and durability while reducing reliance on patient-administered eye drops. The company’s lead program, OcuRing-K™, is an intraocular implant delivering sustained levels of ketorolac for patients undergoing cataract surgery. LayerBio’s approach aims to address key limitations of conventional therapies and improve compliance, clinical outcomes, and overall patient experience.
Looking for a particular LayerBio, Inc employee's phone or email?
The LayerBio, Inc annual revenue was $202000 in 2026.
Kenneth Mandell is the President and CEO of LayerBio, Inc.
3 people are employed at LayerBio, Inc.
LayerBio, Inc is based in Medford, Massachusetts.
The NAICS codes for LayerBio, Inc are [3254, 325, 32541, 32].
The SIC codes for LayerBio, Inc are [283, 28].